Dear Editor,
In a recent issue of your journal, I have read the article by Bućan et al. with great interest 1 . In their study, the authors report that there was no statistically signifi cant correlation between the duration of type 1 diabetes mellitus (DM) and echocardiographic values. It is known that DM increases the prevalence of cardiovascular diseases (CVD) independently of the underlying coronary artery disease 2 . In the present study by Bućan et al., the mean age of study population was 33 years, and 43.5 years for the oldest group. In a large study that included 3200 patients with type 1 DM, the prevalence of CVD was found to be 6% in the 15-29 age group and 25% in the 45-59 age group. Th e prevalence of CVD was related to the increase in age signifi cantly 3 . Th erefore, this study population may be younger for cardiovascular complications of type 1 DM.
Th e relationship of hyperglycemia with microangiopathy as well as macroangiopathy is more signifi cant in type 1 DM than type 2 DM 4 . In the present study by Bućan et al., HbA1c levels were <9%. Also, patients with hypertension and other heart and kidney diseases were excluded. In this sense, this study population may have a low risk of CVD, especially of systolic dysfunction, which can be a complication of microangiopathy and macroangiopathy.
In a large study which included type 1 DM patients diagnosed at the age of <18 years between 1965 and 1979, CVD was identifi ed as the leading cause of death in diabetes after more than 20 years of duration. In the fi rst 20 years of follow up, the major reasons for complications were acute diabetic complications and endstage renal disease 5 . Also, in the Finnish Diabetic Nephropathy study 6 , excess mortality was only observed in individuals with chronic kidney disease in type 1 DM patients with diabetes duration of over 20 years. Th is fi nding suggests that kidney damage in individuals with type 1 DM refl ects more generalized damage to the cardiovascular system leading to CVD and subsequently to mortality. In the present study by Bućan et al., the mean duration of DM was 11 years and longest duration of DM was 17.1 years. Hence, these durations may be short times to have eff ect on systolic function and cardiovascular damage in type 1 DM patients. A longer follow up period may indicate new fi ndings.
It is known that diastolic dysfunction appears before systolic dysfunction in CVD. Also, impaired left ventricle systolic function has been demonstrated by tissue doppler imaging while ejection fraction is in the normal range 7 . Th erefore, to evaluate the cardiovascular eff ect of DM by ejection fraction only may be a wrong approach. It may cause to miss the early phase of CVD.
In conclusion, the analysis of this study may be improved. Th is study included younger patients, short duration of DM and ejection fraction as echocardiographic parameter. Longer follow up and using more sensitive echocardiographic parameters such as tissue doppler imaging may have eff ect on the results of this study.
